275 related articles for article (PubMed ID: 18328855)
1. Analysis of randomized controlled trials on the effect of magnitude of heart rate reduction on clinical outcomes in patients with systolic chronic heart failure receiving beta-blockers.
Flannery G; Gehrig-Mills R; Billah B; Krum H
Am J Cardiol; 2008 Mar; 101(6):865-9. PubMed ID: 18328855
[TBL] [Abstract][Full Text] [Related]
2. Is target dose of beta-blocker more important than achieved heart rate or heart rate change in patients with systolic chronic heart failure?
Porapakkham P; Porapakkham P; Krum H
Cardiovasc Ther; 2010 Apr; 28(2):93-100. PubMed ID: 20398098
[TBL] [Abstract][Full Text] [Related]
3. [The use of beta blockers in heart failure: clinical studies].
Cobelli F
Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
[TBL] [Abstract][Full Text] [Related]
4. Effects on outcomes of heart rate reduction by ivabradine in patients with congestive heart failure: is there an influence of beta-blocker dose?: findings from the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) study.
Swedberg K; Komajda M; Böhm M; Borer J; Robertson M; Tavazzi L; Ford I;
J Am Coll Cardiol; 2012 May; 59(22):1938-45. PubMed ID: 22617188
[TBL] [Abstract][Full Text] [Related]
5. Comparison of late mortality in hospitalized patients >70 years of age with systolic heart failure receiving beta blockers versus those not receiving beta blockers.
Pascual-Figal DA; Redondo B; Caro C; Manzano S; Garrido IP; Ruipérez JA; Valdés M
Am J Cardiol; 2008 Dec; 102(12):1711-7. PubMed ID: 19064029
[TBL] [Abstract][Full Text] [Related]
6. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
7. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials.
Haas SJ; Vos T; Gilbert RE; Krum H
Am Heart J; 2003 Nov; 146(5):848-53. PubMed ID: 14597934
[TBL] [Abstract][Full Text] [Related]
8. Quantitative relationship between resting heart rate reduction and magnitude of clinical benefits in post-myocardial infarction: a meta-regression of randomized clinical trials.
Cucherat M
Eur Heart J; 2007 Dec; 28(24):3012-9. PubMed ID: 17981830
[TBL] [Abstract][Full Text] [Related]
9. Beta-blocker treatment of chronic systolic heart failure improves prognosis even in patients meeting one or more exclusion criteria of the MERIT-HF study.
Jost A; Rauch B; Hochadel M; Winkler R; Schneider S; Jacobs M; Kilkowski C; Kilkowski A; Lorenz H; Muth K; Zugck C; Remppis A; Haass M; Senges J;
Eur Heart J; 2005 Dec; 26(24):2689-97. PubMed ID: 16183697
[TBL] [Abstract][Full Text] [Related]
10. Association of beta-blocker use with mortality among patients with congestive heart failure in the Cardiovascular Health Study (CHS).
Chan JD; Rea TD; Smith NL; Siscovick D; Heckbert SR; Lumley T; Chaves P; Furberg CD; Kuller L; Psaty BM
Am Heart J; 2005 Sep; 150(3):464-70. PubMed ID: 16169325
[TBL] [Abstract][Full Text] [Related]
11. Role of heart rate in cardiovascular diseases: how the results of the BEAUTIFUL study change clinical practice.
Bruguera Cortada J; Varela A
Am J Cardiovasc Drugs; 2009; 9 Suppl 1():9-12. PubMed ID: 20000882
[TBL] [Abstract][Full Text] [Related]
12. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
[TBL] [Abstract][Full Text] [Related]
13. Heart rate control in an unselected consecutive population of outpatients with stable coronary artery disease: Analysis of the CARDIf Study Cohort.
Vitale C; Iellamo F; Volterrani M; Lombardi M; Fini M; Banach M; Rosano GM
Angiology; 2010 Nov; 61(8):763-7. PubMed ID: 20462892
[TBL] [Abstract][Full Text] [Related]
14. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
[TBL] [Abstract][Full Text] [Related]
15. The role of beta-blockers in the treatment of chronic heart failure.
Kubon C; Mistry NB; Grundvold I; Halvorsen S; Kjeldsen SE; Westheim AS
Trends Pharmacol Sci; 2011 Apr; 32(4):206-12. PubMed ID: 21376403
[TBL] [Abstract][Full Text] [Related]
16. A continued role for beta-blocker therapy in heart failure.
Korczyk DP; Doughty RN
Heart Fail Monit; 2006; 5(1):15-9. PubMed ID: 16547531
[TBL] [Abstract][Full Text] [Related]
17. Beta blockers and chronic heart failure patients: prognostic impact of a dose targeted beta blocker therapy vs. heart rate targeted strategy.
Corletto A; Fröhlich H; Täger T; Hochadel M; Zahn R; Kilkowski C; Winkler R; Senges J; Katus HA; Frankenstein L
Clin Res Cardiol; 2018 Nov; 107(11):1040-1049. PubMed ID: 29774407
[TBL] [Abstract][Full Text] [Related]
18. Heart rate in ischemic heart disease. The innovation of ivabradine: more than pure heart rate reduction.
Rosano GM; Vitale C; Volterrani M
Adv Ther; 2010 Apr; 27(4):202-10. PubMed ID: 20495895
[TBL] [Abstract][Full Text] [Related]
19. Association of blood pressure and its evolving changes with the survival of patients with heart failure.
Grigorian-Shamagian L; Gonzalez-JuAnatey JR; Vazquez R; Cinca J; Bayes-Genis A; Pascual D; Fernandez-Palomeque C; Bardaji A; Almendral J; Nieto V; Macaya C; Jimenez RP; de Luna AB;
J Card Fail; 2008 Sep; 14(7):561-8. PubMed ID: 18722321
[TBL] [Abstract][Full Text] [Related]
20. Improved guideline adherence to pharmacotherapy of chronic systolic heart failure in general practice--results from a cluster-randomized controlled trial of implementation of a clinical practice guideline.
Peters-Klimm F; Müller-Tasch T; Remppis A; Szecsenyi J; Schellberg D
J Eval Clin Pract; 2008 Oct; 14(5):823-9. PubMed ID: 19018915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
